MedTrace Logo

Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

NCT07130721 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-08-19

No results posted yet for this study

Summary

This study aims to assess whether two blood markers - C-reactive protein (CRP) and D-dimer - can help predict cardiovascular complications in patients undergoing regular hemodialysis. Cardiovascular disease is a common and serious problem in dialysis patients, and early detection is important.

the study will include 100 adult patients from the Hemodialysis Unit at Assiut University Hospital. Participants will be divided into two groups: those with and those without known heart disease. Each participant will have a one-time blood test to measure CRP and D-dimer levels. In addition, an electrocardiogram (ECG) will be done once to check for signs of heart problems.

Conditions

  • End Stage Renal Disease on Dialysis

Interventions

DIAGNOSTIC_TEST

C-Reactive Protein (CRP) Test

Blood samples will be collected once from all participants to measure CRP levels

DIAGNOSTIC_TEST

D-dimer Test

D-dimer levels will be assessed once to evaluate thrombotic risk.

DIAGNOSTIC_TEST

Electrocardiogram (ECG)

A standard 12-lead ECG will be performed once per participant to assess cardiovascular status

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2026-02-01
Completion
2026-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07130721 on ClinicalTrials.gov